Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aroplatin in Advanced Solid Malignancies
NCT00057395Phase 2Unknown
- Sponsor
- Aronex Pharmaceuticals, Inc.
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal NDDP in solid tumor (advanced stage), sponsored by Aronex Pharmaceuticals, Inc. Primary endpoints: Response Rate (CR, PR) and Duration of Response. Status: unknown.
02
Drugs
liposomal NDDP
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT00057395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057395.